MSB will still be saving insurance companies money compared to existing regimes before approval.
This you fail to mention of course.
The FDA approval is based upon efficacy and that is what referring doctors will use and the insurers will then have little excuse or complaint or reason to say no.
MSB Price at posting:
$2.49 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)